KR101226856B1 - 당질코르티코스테로이드 멸균 현탁액의 제조방법 - Google Patents

당질코르티코스테로이드 멸균 현탁액의 제조방법 Download PDF

Info

Publication number
KR101226856B1
KR101226856B1 KR1020077011131A KR20077011131A KR101226856B1 KR 101226856 B1 KR101226856 B1 KR 101226856B1 KR 1020077011131 A KR1020077011131 A KR 1020077011131A KR 20077011131 A KR20077011131 A KR 20077011131A KR 101226856 B1 KR101226856 B1 KR 101226856B1
Authority
KR
South Korea
Prior art keywords
suspension
glucocorticoid
sterile
vessel
glucocorticosteroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077011131A
Other languages
English (en)
Korean (ko)
Other versions
KR20070089675A (ko
Inventor
존 밀러
폴 로널드
애드리안 애슐리
폴 램
도널드 맥도널드
마틴 올리버
매튜 폴라드
Original Assignee
노턴 헬스케어 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노턴 헬스케어 리미티드 filed Critical 노턴 헬스케어 리미티드
Publication of KR20070089675A publication Critical patent/KR20070089675A/ko
Application granted granted Critical
Publication of KR101226856B1 publication Critical patent/KR101226856B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020077011131A 2004-11-16 2005-11-16 당질코르티코스테로이드 멸균 현탁액의 제조방법 Expired - Lifetime KR101226856B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0425266A GB0425266D0 (en) 2004-11-16 2004-11-16 Pharmaceutical manufacturing process
GB?0425266.4? 2004-11-16
PCT/US2005/041524 WO2006055632A2 (en) 2004-11-16 2005-11-16 Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions

Publications (2)

Publication Number Publication Date
KR20070089675A KR20070089675A (ko) 2007-08-31
KR101226856B1 true KR101226856B1 (ko) 2013-01-25

Family

ID=33523819

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011131A Expired - Lifetime KR101226856B1 (ko) 2004-11-16 2005-11-16 당질코르티코스테로이드 멸균 현탁액의 제조방법

Country Status (16)

Country Link
US (2) US8178519B2 (https=)
EP (1) EP1833462B1 (https=)
JP (1) JP5116478B2 (https=)
KR (1) KR101226856B1 (https=)
CN (2) CN101068531B (https=)
AU (1) AU2005307825C1 (https=)
CA (1) CA2587393C (https=)
CY (1) CY1114150T1 (https=)
DK (1) DK1833462T3 (https=)
ES (1) ES2409713T3 (https=)
GB (1) GB0425266D0 (https=)
IL (2) IL183082A (https=)
PL (1) PL1833462T3 (https=)
PT (1) PT1833462E (https=)
SI (1) SI1833462T1 (https=)
WO (1) WO2006055632A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US10987361B2 (en) 2010-02-08 2021-04-27 Shenzhen Evergreen Therapeutics Co., Ltd. Treating auto-immune and auto-inflammatory diseases
US10993879B2 (en) * 2010-02-08 2021-05-04 Shenzhen Evergreen Therapeutics Co., Ltd. Pulmonary delivery of progestogen
EP3689364A1 (en) 2010-02-08 2020-08-05 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer
WO2011139479A2 (en) 2010-04-30 2011-11-10 H R D Corporation High shear application in drug delivery
US8888736B2 (en) 2010-04-30 2014-11-18 H R D Corporation High shear application in medical therapy
IN2014CH01890A (https=) * 2014-04-10 2015-10-16 Aurobindo Pharma Ltd
JP6521351B2 (ja) * 2014-10-14 2019-05-29 テックプロジェクトサービス株式会社 ウィルス不活化およびサンプリング装置
JP6719459B2 (ja) 2014-10-29 2020-07-08 アール．ピー．シェーラー テクノロジーズ、エルエルシー 逆成形同時充填パッケージング
CN104739811A (zh) * 2015-02-27 2015-07-01 上海臣邦医药科技有限公司 一种糖皮质激素雾化吸入混悬液及其制备方法
EP3386483A4 (en) * 2015-12-07 2019-06-05 Emcure Pharmaceuticals Limited STERILE PARENTERAL SUSPENSIONS
CN106904723A (zh) * 2017-02-24 2017-06-30 东华大学 利用过氧化钙氧化去除水中糖皮质激素的方法
WO2021230342A1 (ja) * 2020-05-15 2021-11-18 大日本印刷株式会社 無菌充填機の洗浄・殺菌方法及び無菌充填機
WO2022098321A1 (en) * 2020-11-09 2022-05-12 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilised suspensions for the administration by inhalation
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
WO2000025746A2 (en) 1998-11-03 2000-05-11 Chiesi Farmaceutici S.P.A. A process for the preparation of suspensions of drug particles for inhalation delivery
WO2004078102A2 (en) 2003-03-04 2004-09-16 Dompe S.P.A. Sterilization of beclomethasone drug particles for pulmonary delivery

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026978A1 (de) * 1990-08-25 1992-02-27 Bayer Ag Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung
GB9410222D0 (en) 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6066292A (en) * 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
EP0938896A1 (en) 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
EP1074369B1 (fr) * 1999-08-04 2005-10-05 Conception et Développement Michelin S.A. Procédé de fabrication de pièces en composite fortement sollicitées
JP4516165B2 (ja) * 1999-08-04 2010-08-04 株式会社ユポ・コーポレーション 多層樹脂延伸フィルム
KR100657729B1 (ko) * 1999-10-21 2006-12-13 신닛테츠가가쿠 가부시키가이샤 적층체 및 그의 제조방법
JP3862924B2 (ja) * 2000-03-27 2006-12-27 日東電工株式会社 光学フィルム積層体
DE60132446T2 (de) * 2000-03-28 2009-01-15 The Board Of Regents Of Oklahoma State University, Stillwater Anordnung selbsttragender filme mittels eines schichtweisen verfahrens
DE60143892D1 (de) * 2000-07-21 2011-03-03 Cellseed Ind Herzmuskel-ähnliche zellschicht, dreidimensionales konstrukt, herzmuskel-ähnliches gewebe und verfahren zur herstellung
BR0115584A (pt) * 2000-11-24 2003-09-23 Breath Ltd Esterilização de produtos farmacêuticos
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US6541309B2 (en) * 2001-03-21 2003-04-01 Hewlett-Packard Development Company Lp Fabricating a molecular electronic device having a protective barrier layer
DE10145361A1 (de) * 2001-09-14 2003-04-03 Pari Gmbh Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation
ITMI20020808A1 (it) 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
GB0410995D0 (en) * 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
WO2000025746A2 (en) 1998-11-03 2000-05-11 Chiesi Farmaceutici S.P.A. A process for the preparation of suspensions of drug particles for inhalation delivery
WO2004078102A2 (en) 2003-03-04 2004-09-16 Dompe S.P.A. Sterilization of beclomethasone drug particles for pulmonary delivery

Also Published As

Publication number Publication date
WO2006055632A3 (en) 2007-05-24
CN101068531B (zh) 2011-10-05
IL228730A (en) 2016-12-29
JP5116478B2 (ja) 2013-01-09
CY1114150T1 (el) 2016-07-27
US8178519B2 (en) 2012-05-15
DK1833462T3 (da) 2013-05-21
KR20070089675A (ko) 2007-08-31
CA2587393C (en) 2010-09-28
EP1833462B1 (en) 2013-04-17
JP2008531467A (ja) 2008-08-14
US20080269178A1 (en) 2008-10-30
CN102327211A (zh) 2012-01-25
AU2005307825C1 (en) 2012-08-09
PL1833462T3 (pl) 2013-10-31
AU2005307825A1 (en) 2006-05-26
IL183082A (en) 2014-09-30
CA2587393A1 (en) 2006-05-26
IL228730A0 (en) 2013-12-31
CN101068531A (zh) 2007-11-07
GB0425266D0 (en) 2004-12-15
ES2409713T3 (es) 2013-06-27
IL183082A0 (en) 2008-03-20
WO2006055632A2 (en) 2006-05-26
PT1833462E (pt) 2013-05-22
AU2005307825B2 (en) 2011-10-13
US20120258939A1 (en) 2012-10-11
SI1833462T1 (sl) 2013-07-31
EP1833462A2 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
US20120258939A1 (en) Pharmaceutical manufacturing process
JP5473029B2 (ja) グルココルチコステロイドの熱滅菌
EP1494647B1 (en) Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation
HK1166689A (en) Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions
AU2012200155A1 (en) Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions
MX2007005681A (en) Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions
EP1683514A1 (en) Concentrated suspensions of drugs and their use to produce suspensions for inhalatory administration
US20150290220A1 (en) Pharmaceutical formualtions comprising a Gluococorticosteroid
HK1171971B (en) Heat sterilization of glucocorticosteroids

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070516

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20070530

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20090415

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110330

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20121130

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130121

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130121

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20160107

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20160107

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20170112

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20170112

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20180111

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20180111

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20190110

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20190110

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20210107

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20231227

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20241224

Start annual number: 13

End annual number: 13